FEASIBILITY STUDIES, CLINICAL TRIAL READINESS, GMP/CLINICAL TRIAL MATERIALS

可行性研究、临床试验准备情况、GMP/临床试验材料

• 批准号: 10721047
• 负责人: MELISSA ALLARD
• 金额: $ 104.61万
• 依托单位: ALBANY MOLECULAR RESEARCH, INC.
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-07-07 至 2027-07-06
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10721047
• 关键词: Clinical Trials; Feasibility Studies; Formulation; Helping to End Addiction Long-term; Pain; Pain management; Pharmaceutical Preparations; Speed; United States National Institutes of Health; clinical pain; clinical trial readiness; programs

This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to understand the basis of pain and enhance clinical pain management.” Drug Manufacturing and Formulation Program; FEASIBILITY STUDIES; CLINICAL TRIAL READINESS; Good Manufacturing Practice; CLINICAL TRIAL MATERIALS

这项研究是NIH帮助结束长期成瘾（HEAL）计划的一部分，旨在加速科学解决方案，以了解疼痛的基础并加强临床疼痛管理。 药物生产和配方计划;可行性研究;临床试验准备;药品生产质量管理规范;临床试验材料